Sequence variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinomas and healthy donors from southern and northern China
- PMID: 29797589
- DOI: 10.1002/jmv.25233
Sequence variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinomas and healthy donors from southern and northern China
Abstract
The BamHI A rightward frame 1 (BARF1) gene of the Epstein-Barr virus (EBV) is involved in carcinogenesis and immunomodulation of EBV-associated malignancies. The geographical distributions and the disease associations of BARF1 variants remain unclear. In the current study, the BARF1 variants in nasopharyngeal carcinoma (NPC) cases and healthy donors from southern and northern China, the NPC endemic and non-endemic areas, as well as in 153 sequenced EBV genomes from diseased and normal people from around the world, were determined and compared among areas and populations. Only 1 consistent coding change, V29A, and several consistent silent mutations were identified. Two BARF1 types (B95-8 and V29A) and 2 B95-8 subtypes (B95-8t165545c and B95-8P ) were classified. For Chinese isolates, the B95-8 type was dominant in both southern and northern China, but the isolates from southern China showed a higher frequency of the B95-8t165545c subtype than the isolates from northern China (76.0%, 38/50 NPC cases and 50.7%, 37/73 healthy donors vs 26.4%, 24/91 NPC cases and 7.6%, 6/79 healthy donors, P < .0001). Furthermore, the B95-8t165545c subtype was more frequent in NPC cases than healthy donors in both southern China (P = .005) and northern China (P = .001). For EBV genomes, the B95-8P subtype was dominant in northern China, Europe, America, and Australia, while V29A was dominant in Africa. The B95-8t165545c subtype was only identified in Asia and demonstrated high frequency (81.2%, 26/32) in genomes from NPC cases in southern China. These results further reveal conservation and possibly geographically spread variations of BARF1 and may also indicate the preference of EBV strains with the B95-8t165545c subtype in NPC cases, without biological or pathogenic implications.
Keywords: BARF1; Epstein-Barr virus (EBV); nasopharyngeal carcinoma; variation.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies.Cancers (Basel). 2020 Jul 17;12(7):1940. doi: 10.3390/cancers12071940. Cancers (Basel). 2020. PMID: 32708965 Free PMC article. Review.
-
Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies.Virus Res. 2012 Jun;166(1-2):23-30. doi: 10.1016/j.virusres.2012.02.022. Epub 2012 Mar 1. Virus Res. 2012. PMID: 22406129
-
Sequence analysis of Epstein-Barr virus (EBV) early genes BARF1 and BHRF1 in NK/T cell lymphoma from Northern China.Virol J. 2015 Sep 4;12:135. doi: 10.1186/s12985-015-0368-3. Virol J. 2015. PMID: 26337172 Free PMC article.
-
Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma.Infect Agent Cancer. 2010 Sep 19;5:16. doi: 10.1186/1750-9378-5-16. Infect Agent Cancer. 2010. PMID: 20849661 Free PMC article.
-
Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis.Semin Cancer Biol. 2012 Apr;22(2):162-5. doi: 10.1016/j.semcancer.2011.12.007. Epub 2011 Dec 24. Semin Cancer Biol. 2012. PMID: 22210180 Review.
Cited by
-
Role of BamHI-A Rightward Frame 1 in Epstein-Barr Virus-Associated Epithelial Malignancies.Biology (Basel). 2020 Dec 11;9(12):461. doi: 10.3390/biology9120461. Biology (Basel). 2020. PMID: 33322292 Free PMC article. Review.
-
The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies.Cancers (Basel). 2020 Jul 17;12(7):1940. doi: 10.3390/cancers12071940. Cancers (Basel). 2020. PMID: 32708965 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources